Skip to main content

Table 2 The results of eleven selected miRNAs analyzed by RT-qPCR

From: Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC)

miRNA serum Group N Mean+/−SD p
miR-31 neoplastic 66 0,345 ± 0,090 <  0,001
control 100 0,078 ± 0,036
miR-141 neoplastic 66 0,289 ± 0,079 <  0,001
control 100 0,077 ± 0,082
miR-149a neoplastic 66 0,168 ± 0,051 0,003
control 100 0,120 ± 0,028
miR-182 neoplastic 66 0,247 ± 0,091 <  0,001
control 100 0,085 ± 0,076
miR-145 neoplastic 66 0,031 ± 0,017 <  0,001
control 100 0,146 ± 0,124
miR-223 neoplastic 66 0,038 ± 0,032 <  0,001
control 100 0,102 ± 0,035
LET-7a neoplastic 66 0,298 ± 0,110 <  0,001
control 100 0,073 ± 0,034
miR-133a neoplastic 66 0,058 ± 0,024 0,007
control 100 0,204 ± 0,156
miR-485-3p neoplastic 66 0,394 ± 0,111 <  0,001
control 100 0,136 ± 0,078
miR-122 neoplastic 66 0,497 ± 0,202 <  0,001
control 100 0,147 ± 0,058
miR-33 neoplastic 66 1013 ± 0,184 <  0,001
control 100 0,136 ± 0,071
  1. Significantly differentially expressed miRNAs in the serum of LSCC patients (n = 66) when compared to healthy controls (n = 100). Data represent the mean ± S.D